European Pharmaceutical Review

JANUARY 18, 2024

GlobalData’s Analyst covering Neurology and Ophthalmology, Thomas Parker, MPharmacol, predicted that Belsomra would lead the market by 2023. Comparatively, in 2015, GlobalData’s research expected that sales of therapies for Gaucher disease will reach $1.16 million in sales by 2032. billion by 2024.

Marketing 98

Marketing Sales Pharmacology Pharma 98

European Pharmaceutical Review

MARCH 11, 2024

In fact, a study published in 2023 in The Lancet HIV revealed that women and men with HIV at age 40 had an average of 39 and 37 years of life left, respectively – only a few years less than that of the general population – if they started antiretroviral therapy (ART) after 2015. World Health Organization. The Global Health Observatory.

Medicine 98

Medicine Pharmacology Healthcare Healthcare 98

pharmaphorum

JANUARY 16, 2023

Across swathes of primary care, pharmacological innovation has stalled; the last new antihypertensive class was introduced in 2007 and new antibiotics have trickled in at a dangerously slow pace. Alzheimer’s is currently the seventh-leading cause of death globally and growing fast.

FDA 85

FDA Healthcare Healthcare Medicine 85

European Pharmaceutical Review

FEBRUARY 14, 2024

Firstly, the pharmacological response to LBPs does not follow traditional pharmacokinetic principles. LBP drug substance production considerations Lead candidate strains are often isolated from healthy human subjects to establish a master cell bank (MCB). 2015; 69(1):381–403 5. 2021; 19:100306 4.

Food and Drug Administration 97

Food and Drug Administration Manufacturing Engineering Pharmacology 97